Home LiteratureArticle Details
PMID: 15931391 Published · ppublish English Comparative Study Journal Article

Host control of Mycobacterium tuberculosis is regulated by 5-lipoxygenase-dependent lipoxin production.

The Journal of clinical investigation ·Vol. 115 ·No. 6 ·2005-06-00 ·Pages 1601-6

Bafica A, Scanga CA, Serhan C, Machado F, White S, Sher A, Aliberti J

Abstract

Th1 type cytokine responses are critical in the control of Mycobacterium tuberculosis infection. Recent findings indicate that 5-lipoxygenase-dependent (5-LO-dependent) lipoxins regulate host IL-12 production in vivo. Here, we establish lipoxins as key chemical mediators in resistance to M. tuberculosis infection. High levels of lipoxin A4 (LXA4) were detected in sera from infected WT but not infected 5-LO-deficient mice. Moreover, lungs from M. tuberculosis-infected 5-lo-/- animals showed increased IL-12, IFN-gamma, and NO synthase 2 (NOS2) mRNA levels compared with the same tissues in WT mice. Similarly, splenocyte recall responses were enhanced in mycobacteria-infected 5-lo-/- versus WT mice. Importantly, bacterial burdens in 5-lo-/- lungs were significantly lower than those from WT mice, and this enhancement in the resistance of the 5-lo-/- animals to M. tuberculosis was completely prevented by administration of a stable LXA4 analog. Together our results demonstrate that lipoxins negatively regulate protective Th1 responses against mycobacterial infection in vivo and suggest that the inhibition of lipoxin biosynthesis could serve as a strategy for enhancing host resistance to M. tuberculosis.

MeSH Terms
Animals Arachidonate 5-Lipoxygenase/deficiency,metabolism Cytokines/biosynthesis Lipoxins/administration & dosage,biosynthesis,genetics Lung/immunology,microbiology,pathology Mice Mice, Knockout Mycobacterium tuberculosis/immunology Nitric Oxide Synthase/biosynthesis Spleen/cytology,immunology Th1 Cells/cytology,immunology Tuberculosis, Pulmonary/drug therapy,immunology,pathology
Chemicals
Cytokines Lipoxins lipoxin A4 Arachidonate 5-Lipoxygenase Nitric Oxide Synthase
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Bafica Andre
Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.
Scanga Charles A
Serhan Charles
Machado Fabiana
White Sandy
Sher Alan
Aliberti Julio
References (30)
30 references, click to expand
  1. The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection.
    Immunology. 1995 Mar;84(3):423-32 PMID: 7751026
  2. Action of novel eicosanoids lipoxin A and B on human natural killer cell cytotoxicity: effects on intracellular cAMP and target cell binding.
    J Immunol. 1985 Nov;135(5):3434-8 PMID: 2995494
  3. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection.
    J Immunol. 1995 Sep 1;155(5):2515-24 PMID: 7650381
  4. Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial. Zileuton Clinical Trial Group.
    JAMA. 1996 Mar 27;275(12):931-6 PMID: 8598621
  5. Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection.
    N Engl J Med. 1996 Dec 26;335(26):1956-61 PMID: 8960475
  6. Identification of nitric oxide synthase as a protective locus against tuberculosis.
    Proc Natl Acad Sci U S A. 1997 May 13;94(10):5243-8 PMID: 9144222
  7. Randomized trial of zileuton in patients with moderate asthma: effect of reduced dosing frequency and amounts on pulmonary function and asthma symptoms. Zileuton Study Group.
    Am J Manag Care. 1997 Apr;3(4):633-40 PMID: 10169531
  8. A randomized controlled trial comparing zileuton with theophylline in moderate asthma. The Zileuton Study Group.
    Arch Intern Med. 1998 Jan 26;158(2):141-8 PMID: 9448552
  9. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency.
    Science. 1998 May 29;280(5368):1432-5 PMID: 9603732
  10. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients.
    Science. 1998 May 29;280(5368):1435-8 PMID: 9603733
  11. Lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor 1alpha-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis.
    J Exp Med. 1999 Jun 21;189(12):1923-30 PMID: 10377187
  12. Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo.
    Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):8247-52 PMID: 10393980
  13. A synthetic eicosanoid LX-mimetic unravels host-donor interactions in allogeneic BMT-induced GvHD to reveal an early protective role for host neutrophils.
    FASEB J. 2005 Feb;19(2):203-10 PMID: 15677343
  14. Host persistence: exploitation of anti-inflammatory pathways by Toxoplasma gondii.
    Nat Rev Immunol. 2005 Feb;5(2):162-70 PMID: 15662369
  15. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice.
    Immunity. 1995 Jun;2(6):561-72 PMID: 7540941
  16. Cutting edge: lipoxin (LX) A4 and aspirin-triggered 15-epi-LXA4 block allergen-induced eosinophil trafficking.
    J Immunol. 2000 Mar 1;164(5):2267-71 PMID: 10679058
  17. Effects of modulating TGF-beta 1 on immune responses to mycobacterial infection in guinea pigs.
    Tuber Lung Dis. 1999;79(4):207-14 PMID: 10692988
  18. Endogenous inhibition of antimycobacterial immunity by IL-10 varies between mycobacterial species.
    Scand J Immunol. 2001 Jul-Aug;54(1-2):163-70 PMID: 11439163
  19. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.
    N Engl J Med. 2001 Oct 11;345(15):1098-104 PMID: 11596589
  20. Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity.
    Nat Immunol. 2002 Jan;3(1):76-82 PMID: 11743584
  21. Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia.
    Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3902-7 PMID: 11891303
  22. Evidence inconsistent with a negative influence of T helper 2 cells on protection afforded by a dominant T helper 1 response against Mycobacterium tuberculosis lung infection in mice.
    Infect Immun. 2002 Nov;70(11):6436-43 PMID: 12379724
  23. Parasite-induced lipoxin A4 is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection.
    J Exp Med. 2002 Nov 4;196(9):1253-62 PMID: 12417634
  24. Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution.
    Prostaglandins Other Lipid Mediat. 2002 Aug;68-69:433-55 PMID: 12432935
  25. Increased interleukin-10 expression is not responsible for failure of T helper 1 immunity to resolve airborne Mycobacterium tuberculosis infection in mice.
    Immunology. 2003 Jun;109(2):295-9 PMID: 12757625
  26. Expression of BPI (bactericidal/permeability-increasing protein) in human mucosal epithelia.
    Biochem Soc Trans. 2003 Aug;31(Pt 4):795-800 PMID: 12887308
  27. Genetic susceptibility to pulmonary tuberculosis in Cambodia.
    Tuberculosis (Edinb). 2004;84(1-2):76-81 PMID: 14670348
  28. Exogenous pathogen and plant 15-lipoxygenase initiate endogenous lipoxin A4 biosynthesis.
    J Exp Med. 2004 Feb 16;199(4):515-23 PMID: 14970178
  29. MyD88-deficient mice display a profound loss in resistance to Mycobacterium tuberculosis associated with partially impaired Th1 cytokine and nitric oxide synthase 2 expression.
    Infect Immun. 2004 Apr;72(4):2400-4 PMID: 15039368
  30. Lipoxins and novel 15-epi-lipoxin analogs display potent anti-inflammatory actions after oral administration.
    Br J Pharmacol. 2004 Sep;143(1):43-52 PMID: 15302682
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
2005-06-00
Pages
1601-6
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC1136995
Subset
IM
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com